维普期刊资源整合服务平台（V6.5）

25篇 您的检索式：作者名="Dang NH"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Phase Ⅱ trial ofdenileukin diftitox for relapsed/refractory T-cell non-Hodgkin lymphoma 显示文摘	Dang NH Pro B Hagemeister FB	2007	Br J Haematol2007，136，3：	1
2	Chemotherapy for advanced non-small cell lung cancer 显示文摘	Herbst RS Dang NH Skarin AT	1997	Hematol Oncol Clin North Am1997，11，3：	1
3	Flavonoid glycosides from Chro-molaena odorata leaves and their in vitro cytotoxic activity显示文摘	Hung TM Cuong TD Dang NH	2011	Chem Pharm Bull(Tokyo)2011，59，1：	1
4	Phase Ⅱ trial of denileukin diftitox for relapsed/refractory T-cell non-Hodgkin lymphoma显示文摘	Dang NH Pro B Hagemeister FB	2007	Br J Haematol2007，136，3：	1
5	1 F7 (CD26) : a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation显示文摘	Dang NH Torimoto Y Shimamura K	1991	J Immunol1991，147，9：	1
6	Phase Ⅱtrial of denileukin diftitox for relapsed/refractory T-cell non-Hodgkin lymphoma显示文摘	Dang NH Pro B Hagemeister FB	2007	Br J Haematol2007，136，3：	1
7	Interim analysis of a phase Ⅱ study of denileukin diftitox (Ontak) for relapsed/refractory T-cell non-Hodkin's lympoma 显示文摘	Dang NH Pro B Hagemeister FB	2004	Blood2004，104，11：	1
8	Chemotherapy for advanced non-small cell lung cancer显示文摘	Dang NH Skarin AT	1997	Hematol/Oncol Clin North Am1997，11，3：	1
9	Phase Ⅱ trial of denileukin diftitox for relapsed/refractory T-cell non-Hodgkin lymphoma显示文摘	Dang NH Pro B Hagemeister FB	2007	Br J Haematol2007，136，3：	1
10	Phase II trial of denileukin diftitox for relapsed/refractory T - cell non - Hodgkin lymphoma显示文摘	Dang NH Pro B Hagemeister FB	2007	Brit J Haematol2007，136，3：	1
11	Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/ refractory B-cell non-Hodgkin lyrnphoma显示文摘	Dang NH Fayad L McLaughlin P	2007	Br J Haematol2007，138，4：	1
12	Phase II trial of denileukin diftitox for relapsed/refractory T-cell non-Hodgkin lymphoma显示文摘	Dang NH Pro B Hagemeister FB	2007	Br J Haematol2007，136，3：	1
13	Absence of CD26 expression is a useful marker for diagnosis of T-ceil lymphoma in peripheral blood显示文摘	Jones D Dang NH Duvic M	2001	Am J Clin Pathol2001，115，6：	1
14	Flavonoid glycosides from Chro- molaena odorato leavesand their in vitro cytotoxic aetivity 显示文摘	Hung TM Cuong TD Dang NH	2011	Chem pharm Bull(Tokyo)2011，59，1：	1
15	Denileukin difiitox as novel targeted therapy for lymphoid malignancies 显示文摘	WANG BY GREGORY SA DANG NH	2007	Cancer Invest2007，25，6：	1
16	Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function显示文摘	Ohnuma K Dang NH Morimoto C	2003	Trends Immunol2003，29，6：	1
17	Chemotherapy for advanced non-small cell lung cancer显示文摘	Dang NH Skarin AT	1997	Hematol/Oncol Clin North Am1997，11，3：	1
18	Phase II trail of denileukin diflitox for relapsed/refractory T-cell non-Hodgkin lymphoma显示文摘	Dang NH Pro B Hagemeister FB	2007	BrJ Haematol2007，136，3：	1
19	CD26/dipeptidyl peptidase IV and its role in cancer显示文摘	Pro B Dang NH	2004	Histol Histopathol2004，19，4：	1
20	Phase II trial of denileu- kin diftitox for relapsed/refractory T - cell non- Hodgkin lympho- ma显示文摘	Dang NH Pro B Hagemeister FB	2007	Br J Hacmatol2007，136，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示